Literature DB >> 34748043

Letter to the editor on "Perfluorobutane contrast-enhanced ultrasonography for the diagnosis of HCC: a systematic review and meta-analysis".

Jiangfeng Wu1, Lijing Ge2, Lili Lu2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34748043     DOI: 10.1007/s00261-021-03338-8

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


× No keyword cloud information.
  3 in total

1.  Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.

Authors:  Kazue Shiozawa; Manabu Watanabe; Ryuji Takayama; Masayoshi Takahashi; Noritaka Wakui; Kazunari Iida; Yasukiyo Sumino
Journal:  J Clin Ultrasound       Date:  2010-05       Impact factor: 0.910

2.  Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study.

Authors:  Tatsuo Inoue; Tomoko Hyodo; Keiko Korenaga; Takamichi Murakami; Yasuharu Imai; Atsushi Higaki; Takeshi Suda; Toru Takano; Kennichi Miyoshi; Masahiko Koda; Hironori Tanaka; Hiroko Iijima; Hironori Ochi; Masashi Hirooka; Kazushi Numata; Masatoshi Kudo
Journal:  J Gastroenterol       Date:  2015-09-15       Impact factor: 7.527

3.  Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.

Authors:  Matthew D F McInnes; David Moher; Brett D Thombs; Trevor A McGrath; Patrick M Bossuyt; Tammy Clifford; Jérémie F Cohen; Jonathan J Deeks; Constantine Gatsonis; Lotty Hooft; Harriet A Hunt; Christopher J Hyde; Daniël A Korevaar; Mariska M G Leeflang; Petra Macaskill; Johannes B Reitsma; Rachel Rodin; Anne W S Rutjes; Jean-Paul Salameh; Adrienne Stevens; Yemisi Takwoingi; Marcello Tonelli; Laura Weeks; Penny Whiting; Brian H Willis
Journal:  JAMA       Date:  2018-01-23       Impact factor: 56.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.